Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. F. Nitu, M. Olteanu, C. Calarasu, M. Olteanu, A. Miulescu, D. Ardelean, I. Vasilache (Craiova, Romania). Lung involvement in multiple myeloma - study case. Eur Respir J 2013; 42: Suppl. 57, 2374

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic lung disease Source: International Congress 2016 – Orphan diseases I Year: 2016 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia Source: International Congress 2014 – ILDs 2 Year: 2014 Clinical and immunological parameters in patients with newly diagnosed sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Source: International Congress 2015 – IIPs: orphan Year: 2015 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease Source: Eur Respir Rev 2010 19: 237-241 Year: 2010 Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study Source: International Congress 2016 – ILD pathogenesis Year: 2016 Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Bronchoalveolar lavage cytokine profile in patients with Pulmonary Langerhans Cell Histiocytosis differs from other interstitial lung diseases Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Source: International Congress 2015 – New insights into IIPs Year: 2015 Cytofluorimetric BAL cells characterization in IPF and in other ILD Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 BAL findings in desquamative interstitial pneumonia (DIP) and other idiopathic interstitial pneumonia (IIP) Source: International Congress 2014 – ILDs 4 Year: 2014 Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases Source: International Congress 2016 – Connective tissue disorders Year: 2016 Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis Source: International Congress 2016 – Connective tissue disorders Year: 2016 Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Bronchoalveolar lavage Source: Eur Respir Mon; 2010: 48: 59–72 Year: 2010 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006